To register, you can use your prescription ID or your social security number
Seek immediate emergency care (call 911 or go to the emergency department) for: Sudden severe chest pain or pressure Difficulty breathing or shortness of breath at rest Coughing up blood Sudden weakness, numbness, difficulty speaking, vision changes, or severe headache (stroke symptoms) Severe leg pain with swelling and skin color changes Fainting or loss of consciousness Sudden severe abdominal pain (which could indicate pancreatitis, a known rare semaglutide risk) Signs of severe allergic reaction (rash, itching, swelling of face/throat, difficulty breathing) Contact your healthcare provider within 24 hours for: New or worsening leg swelling, especially if unilateral Persistent calf pain or tenderness Unexplained shortness of breath with exertion New onset of rapid heart rate Persistent severe nausea or vomiting preventing adequate hydration Sudden vision changes (potential retinopathy complication) Right upper quadrant pain, fever, or yellowing of skin/eyes (potential gallbladder disease) Markedly decreased urination (potential kidney issue) Positive pregnancy test (semaglutide should be discontinued) Schedule a routine appointment to discuss: Planned surgeries or procedures New medications or supplements Significant changes in activity level or mobility Pregnancy planning (semaglutide should be discontinued at least 2 months before planned conception) Concerns about medication side effects Difficulty with injection technique or medication adherence Patients should generally not discontinue semaglutide abruptly without medical guidance, as this may affect glycemic control in those with diabetes
When in Doubt, Contact Your Healthcare Provider If youre ever unsure about a symptom, dont hesitate to contact your healthcare provider
Pricing Transparency Fixed Pricing and Discounts Reflex MD is committed to pricing transparency with a fixed subscription fee model
Its about corruption and trust
This study demonstrated that -LA supplementation (300 mg/d, twice a day) for 3 months significantly decreased the serum levels of MDA and C-reactive protein (CRP), as two inflammatory and oxidative stress markers, and mood disorders in patients with episodic migraine
